Gastrointestinal Products Market | Gastroenterology Products Market Size, Share & Trends by Devices (Endoscopy, Ablation system, Motility testing, Biopsy devices, Stenting devices, pH monitoring), Diseases (GERD), (IBD), Gastrointestinal cancer), End-User (Hospitals, ASC) - Global Forecast to 2029
Gastrointestinal Products Market Size, Share & Trends
The gastrointestinal products market is expected to generate a revenue of USD 19.7 billion by 2029, with a revenue of USD 14.7 billion in 2024 to register a CAGR of 6.1%. Market growth can be attributed to the growing prevalence of gastrointestinal diseases such as Crohn's disease, ulcerative colitis, irritable bowel syndrome (IBS), and colorectal cancer, which drives the demand for diagnostic and therapeutic products. Poor dietary habits, sedentary lifestyles, and increasing stress levels contribute to the rise in GI disorders, thereby boosting the market.
Gastroenterology devices are becoming increasingly innovative. Next-generation endoscopy technologies, like high-definition imaging and narrow-band imaging, develop better visualization throughout the procedure. Another important trend is the integration of AI and machine learning, which provide real-time analysis and early identification of conditions such as colorectal cancer. Capsule endoscopy, where one swallows a small camera that captures the image of the GI tract, is gaining popularity in non-invasive diagnostics. Robotic-assisted devices are also becoming popular.
Gastroenterology Products Market Trends
To know about the assumptions considered for the study, Request for Free Sample Report
Global Gastrointestinal Products Market Dynamics
Driver: Increased prevalence of GI disorders
The increasing incidence of gastrointestinal disorders is a key factor driving growth in the gastrointestinal products market. The incidence of GI disorders, such as Crohn's disease, ulcerative colitis, irritable bowel syndrome, and colorectal cancer, is increasing across the globe. This will, in turn, increase the demand for diagnostic and associated therapeutic interventions. Other contributing factors for this increased prevalence of diseases (such as colorectal cancer, inflammatory bowel disease, and gastroesophageal reflux disease) include the rapidly increasing geriatric population, unhealthy lifestyles, and poor eating habits. There is a growing demand for sophisticated medical devices in diagnosing, monitoring, and treating such diseases with a high degree of accuracy due to the increasing prevalence of these diseases. It is this surge in demand that fuels innovations and investments in the development of new and improved gastrointestinal devices, such as endoscopes and imaging systems.
Restraint: Stringent regulatory policies for GI products
A major restraint in the gastroenterology product market is the stringent regulatory policies, which create strong barriers against the development and commercialization of new treatment solutions. Regulatory approvals for GI products require detailed development processes, including extensive preclinical studies, prolonged clinical trials, and comprehensive assessments of safety and efficacy. These steps are costly and time-consuming, which invariably delays the launch of innovative products. Furthermore, the high expenses associated with complying with such regulatory requirements may be prohibitive, particularly for smaller companies with limited financial resources. These challenges are further magnified by the need for constant post-marketing surveillance to monitor the long-term safety impact, which further entails financial and administrative investments. As a result, the pace of innovation is slow, potentially delaying the development of effective treatments for GI disorders and impacting overall market growth.
Opportunity: Increasing preference for minimally invasive procedures for gastrointestinal diseases
Minimally invasive surgeries, such as laparoscopy, have been replacing open surgery in the past few years due to improved survival, fewer complications, and rapid recoveries. These less-invasive surgeries involve very small incisions, less pain, and allow for faster recovery. Patients spend less time in the hospital and recover faster with fewer complications, such as infections, hernias, and adhesions, and less scarring inside and out. This is a key opportunity area for players in the gastrointestinal products market.
Challenge: Regulatory landscape for medical devices
New regulations make it difficult for device manufacturers to realize profits. Enhanced requirements regarding scientific studies and clinical trials raise device development costs. The procedure for approving devices and maintaining their certification is time-consuming. Not only does this challenge the revenue margins for manufacturers, but it also increases the device costs for customers. This could be of special concern to small device manufacturers or start-ups, who may find it hard to secure funds for stricter rules of device documentation and clinical testing.
Gastrointestinal Products Industry Ecosystem
The devices segment witnessed the highest growth in the global gastrointestinal products industry during the forecast period.
Based on devices, the gastrointestinal products market is segmented into endoscopy devices, ablation devices, motility testing devices, biopsy devices, stenting devices, pH monitoring devices, and other gastroenterology devices. The endoscopy devices segment accounted for the largest market share in 2023. These devices are of vital importance for the diagnosis and treatment of various gastrointestinal diseases. In minimally invasive endoscopy procedures, there is better visualization of the digestive tract, which especially permits accurate diagnosis, early detection of diseases such as cancer, and proper treatment by polyp removal or bleeding arrest. The demand for endoscopic apparatuses comes as a result of the rising incidence of gastrointestinal diseases and the versatility of endoscopy in therapeutic and diagnostic applications. Moreover, technological innovations, like high-definition imaging and capsule endoscopy, further improve the scope and success rate of endoscopic procedures.
Gastrointestinal cancers commanded the largest share of the gastroenterology products industry, by disease, in 2023.
Gastrointestinal cancers are becoming more frequent due to demographic changes, most commonly as a result of aging populations, lifestyle modifications, and environmental factors. Other risk factors include unhealthy diets, obesity, smoking, and alcohol consumption, which increase the chances of cancers arising in the digestive system. The increasing prevalence of other types of infections, like Helicobacter pylori and Hepatitis, which give way to stomach and liver cancers, also adds to the overall disease burden. Gastrointestinal cancers constitute a large portion of the global cancer burden since they lead to cancers of the organs that play a crucial role in the body's digestive and metabolic processes—the stomach, liver, pancreas, and colon. These complex factors, including stage diagnosis and treatment challenges, contribute to the significant impact of cancers on global cancer mortality and healthcare expenses.
Hospitals account for the largest share of the gastrointestinal products industry, by end user, during the forecast period.
Gastrointestinal disorders often demand the utilization of high-end imaging technology, endoscopic procedures, and surgery, which are usually undertaken within hospital settings. This is because hospitals have the capability and infrastructure to provide inpatient care services in addition to all the patient care facilities and the requirements that go with such services, including pre-surgical dressings, operation, postoperative care, and care during the follow-up period. Moreover, hospitals have higher caseloads and, consequently, serve as referral centers for patients with severe or complicated conditions that cannot be managed at outpatient facilities. This drives the demand for a wide range of gastrointestinal devices. Hospitals are also more likely to invest in these devices because they require and can afford high-cost equipment.
North America accounted for the largest share of the gastroenterology products industry in 2023.
Based on regions, the gastroenterology products market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the gastrointestinal products market in 2023. This is due to the increased prevalence of GI disorders, such as GERD, cancer, and autoimmune disorders. North America has one of the world's highest healthcare expenditures per capita. Significant investments in healthcare infrastructure, research, and pharmaceuticals help to promote the widespread use of GI products in the region.
To know about the assumptions considered for the study, download the pdf brochure
Prominent players in the gastrointestinal products market are Boston Scientific (US), Medtronic (US), Olympus Corporation (Japan), Fujifilm Corporation (Japan), and Stryker (US).
Scope of the Gastrointestinal Products Industry
Report Metric |
Details |
Market Revenue Size in 2024 |
USD 14.7 billion |
Projected Revenue Size by 2029 |
USD 19.7 billion |
Industry Growth Rate |
Poised to Grow at a CAGR of 6.1% |
Market Driver |
Increased prevalence of GI disorders |
Market Opportunity |
Increasing preference for minimally invasive procedures for gastrointestinal diseases |
This report categorizes the gastrointestinal products market to forecast revenue and analyze trends in each of the following submarkets:
By Devices
- Introduction
-
Endoscopy
- Colonoscopy
- Sigmoidoscopes
- Capsule endoscopy systems
- Other endoscopy devices
- Other endoscopic accessory products
-
Ablation system
- Radiofrequency Ablation system
- Microwave Ablation System
- Cryoablation system
- Other ablation system
-
Motility testing
- Esophageal Manometry
- 4-Hour pH Impedance Testing
- Anorectal Manometry
- Other Motility testing
-
Biopsy Devices
- Needle biopsy devices
- Endoscopic mucosal resection (EMR) devices
- Endoscopic submucosal dissection (ESD) devices
- Other biopsy accessory products
-
Stenting Devices
- Biliary Stents
- Pancreatic Stents
- Colonic Stents
-
pH Monitoring Devices
- Esophageal pH Monitoring Catheters
- Wireless pH Monitoring Capsules
- Ambulatory pH Monitoring Systems
-
Other Gastroenterology Devices
- Gastric Balloons
- Gastrointestinal Tubes
- Hemorrhoid Treatment Devices
By Disease
- Introduction
- Inflammatory Bowel Disease (IBD)
- Gastroesophageal Reflux Disease (GERD)
- Irritable Bowel Syndrome (IBS)
- Gastrointestinal Cancer
- Other diseases
End-User
- Introduction
- Hospitals
- Ambulatory Surgical Centers and Independent Diagnostic Centers
- Clinics
- Other end users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- Italy
- Spain
- France
- Rest of Europe (RoE)
-
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia Pacific (RoAPAC)
-
Latin America
- Brazil
- Mexico
- Rest of Latin America
-
Middle East and Africa
- GCC Countries
- Rest of Middle East and Africa
Recent Developments of Gastroenterology Products Industry:
- In April 2023, Boston Scientific announced the launch of the EXALT Model B Single-use Bronchoscope, which expands its single-use endoscopy portfolio. This device is designed for diagnostic and therapeutic bronchoscopy procedures and offers high-resolution imaging and precise control.
- In March 2021 Medtronic introduced the GI Genius Intelligent Endoscopy Module. This module uses artificial intelligence to detect colorectal polyps during colonoscopies, providing real-time insights to physicians. The technology aims to improve adenoma detection rates and enhance the overall diagnostic accuracy of endoscopic procedures.
Frequently Asked Questions (FAQ):
What is the expected addressable market value of the gastrointestinal products market over 5 years?
The gastrointestinal products market is projected to reach USD 19.7 billion by 2029, at a CAGR of 6.1% during the forecast period.
Which application segment is expected to garner the highest traction within the gastroenterology products market?
The GERD application segment is expected to witness the highest growth in the gastroenterology products market.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
- 5.1 INTRODUCTION
-
5.2 MARKET DYNAMICSDRIVERS- Rising prevalence of GI disorders- Technological advancements in gastroenterology products- Growing aging populationRESTRAINTS- Stringent regulatory policies for GI products- Increasing healthcare costs- Unfavorable healthcare reforms in USOPPORTUNITIES- Increasing preference for minimally invasive surgeryCHALLENGES- Changing regulatory landscape- Shortage of trained physicians and endoscopists
- 5.3 INDUSTRY TRENDS
-
5.4 TECHNOLOGY ANALYSISKEY TECHNOLOGIES- Capsule endoscopyCOMPLEMENTARY TECHNOLOGIES- Laboratory testingADJACENT TECHNOLOGIES- Robotic surgery systems
- 5.5 VALUE CHAIN ANALYSIS
-
5.6 PORTER’S FIVE FORCE ANALYSISTHREAT OF NEW ENTRANTSTHREAT OF SUBSTITUTESBARGAINING POWER OF SUPPLIERSBARGAINING POWER OF BUYERSINTENSITY OF COMPETITIVE RIVALRY
-
5.7 REGULATORY LANDSCAPEREGULATORY ANALYSIS- North America- Europe- Asia PacificREGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
-
5.8 PATENT ANALYSISPATENT PUBLICATION TRENDS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTSINSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
-
5.9 TRADE ANALYSISHS CODES: GASTROENTEROLOGY/GASTROINTESTINAL INSTRUMENTSIMPORT DATAEXPORT DATA
- 5.10 PRICING ANALYSIS
- 5.11 REIMBURSEMENT ANALYSIS
- 5.12 KEY CONFERENCES & EVENTS, 2024–2025
-
5.13 KEY STAKEHOLDERS & BUYING CRITERIAKEY STAKEHOLDERS IN BUYING PROCESSBUYING CRITERIA
- 5.14 UNMET NEEDS ANALYSIS
- 5.15 END-USER EXPECTATIONS
- 5.16 ECOSYSTEM ANALYSIS
- 5.17 CASE STUDY ANALYSIS
- 5.18 SUPPLY CHAIN ANALYSIS
- 5.19 INVESTMENT & FUNDING SCENARIO
- 5.20 IMPACT OF GEN AI/AI ON GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
- 6.1 INTRODUCTION
-
6.2 ENDOSCOPY DEVICESFLEXIBLE ENDOSCOPES- Advantages such as flexibility and ease of use to drive demand for flexible endoscopesRIGID ENDOSCOPES- Ability of rigid endoscopes to provide vertical-axis images of internal organs to support market growthCAPSULE ENDOSCOPES- Non-invasive nature of capsule endoscopes to drive adoptionOTHER ENDOSCOPY DEVICES
-
6.3 ABLATION DEVICESRADIOFREQUENCY ABLATION DEVICES- Low cost of radiofrequency ablation to contribute to market growthMICROWAVE ABLATION DEVICES- Advantages over RF ablation to ensure sustained demand for microwave ablation devicesCRYOABLATION DEVICES- Increasing cancer incidence to drive market for cryoablation devicesLASER ABLATION DEVICES- High efficacy and safety to drive adoption of laser/light ablation devicesOTHER ABLATION DEVICES
-
6.4 MOTILITY TESTING DEVICESESOPHAGEAL MANOMETRY DEVICES- Rising incidence of esophageal motility disorders to boost market growth4-HOUR PH IMPEDANCE TESTING DEVICES- Ability to provide data useful for tailoring individualized treatment plans to favor market growthANORECTAL MANOMETRY DEVICES- Growing popularity of anorectal manometry devices for diagnosis of gastrointestinal problems to support market growthOTHER MOTILITY TESTING DEVICES
-
6.5 BIOPSY DEVICESNEEDLE BIOPSY DEVICES- Increasing screening of gastrointestinal diseases to aid growthOTHER BIOPSY DEVICES
-
6.6 STENTING DEVICESBILIARY STENTS- Increasing prevalence of bile duct cancer and chronic liver disease to drive growthCOLONIC STENTS- Rising demand for colonic stents due to high incidence of colorectal cancer to drive segmental growthDUODENAL STENTS- Increasing prevalence of intestinal malignancy to boost adoption of duodenal stentsPANCREATIC STENTS- Rising number of ERCP and PTC procedures to drive market growthESOPHAGEAL STENTS- Increasing incidence of esophageal cancer to propel market growth
-
6.7 PH MONITORING DEVICESESOPHAGEAL PH MONITORING CATHETERS- Growing sedentary lifestyles to drive demandWIRELESS PH MONITORING CAPSULES- Reduced risk of open surgeries to boost marketAMBULATORY PH MONITORING SYSTEMS- Convenience and accuracy of ambulatory pH monitoring to drive market
-
6.8 OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICESGASTRIC BALLOONS- Minimally invasive nature of gastric balloons to boost adoptionGASTROINTESTINAL TUBES- Rising incidence of diseases to drive need for gastrointestinal tubesHEMORRHOID TREATMENT DEVICES- Rising cases of hemorrhoids to support market growth
- 7.1 INTRODUCTION
-
7.2 GASTROINTESTINAL CANCERSCHANGING DIETS AND GROWING PREVALENCE OF OBESITY TO BOOST MARKET GROWTH
-
7.3 GASTROESOPHAGEAL REFLUX DISEASEGROWING INCIDENCE OF GERD TO DRIVE MARKET GROWTH
-
7.4 IRRITABLE BOWEL SYNDROME (IBS)GROWING IBS DISEASE BURDEN TO DRIVE DEMAND FOR GASTROINTESTINAL PRODUCTS
-
7.5 INFLAMMATORY BOWEL DISEASE (IBD)GROWING USE OF CAPSULE ENDOSCOPES IN TREATING IBD TO FAVOR MARKET GROWTH
- 7.6 OTHER DISEASES
- 8.1 INTRODUCTION
-
8.2 HOSPITALSHIGH VOLUME OF MINIMALLY INVASIVE PROCEDURES TO DRIVE DEMAND FOR GASTROINTESTINAL PROCEDURES IN HOSPITALS
-
8.3 AMBULATORY SURGICAL CENTERS & INDEPENDENT SURGICAL CENTERSLOWER COSTS AND SHORTER PATIENT STAYS TO DRIVE MARKET GROWTH
-
8.4 CLINICSGROWING NEED FOR CLINICAL SCREENING TO DIAGNOSE GASTROINTESTINAL DISEASES TO BOOST MARKET
- 8.5 OTHER END USERS
- 9.1 INTRODUCTION
-
9.2 NORTH AMERICAMACROECONOMIC OUTLOOK FOR NORTH AMERICAUS- US to dominate North American market during forecast periodCANADA- Increased availability of funding and presence of research institutes to propel market
-
9.3 EUROPEMACROECONOMIC OUTLOOK FOR EUROPEGERMANY- Favorable reimbursement scenario and increased geriatric population to aid market growthUK- Rising investments by hospitals in new and advanced gastroenterology/gastrointestinal products to augment market growthFRANCE- Increase in health expenditure and high prevalence of cancer to stimulate market growthITALY- High per capita income and improved healthcare system to drive marketSPAIN- Growing prevalence of cardiovascular diseases to boost market growthREST OF EUROPE
-
9.4 ASIA PACIFICMACROECONOMIC OUTLOOK FOR ASIA PACIFICJAPAN- Favorable medical device reimbursement policies and public health insurance schemes to aid market growthCHINA- Increasing geriatric population and increase in domestic manufacturers for gastrointestinal products to support growthINDIA- Increasing incidence of diseases like diabetes to enhance market growthAUSTRALIA- High incidence of cancer to propel market growthSOUTH KOREA- Rapidly aging population and high incidence of gastrointestinal diseases to aid market growthREST OF ASIA PACIFIC
-
9.5 LATIN AMERICAMACROECONOMIC OUTLOOK FOR LATIN AMERICABRAZIL- Increase in private healthcare investments and rise in medical tourism to aid market growthMEXICO- Increased government investment in healthcare infrastructure and technological advancements to aid market growthREST OF LATIN AMERICA
-
9.6 MIDDLE EAST & AFRICAMACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICAGCC COUNTRIES- Increasing investment in healthcare infrastructure and growing medical tourism to propel market growthREST OF MIDDLE EAST & AFRICA
- 10.1 OVERVIEW
- 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
- 10.3 REVENUE ANALYSIS, 2021–2023
- 10.4 MARKET SHARE ANALYSIS, 2023
-
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023STARSEMERGING LEADERSPERVASIVE PLAYERSPARTICIPANTSCOMPANY FOOTPRINT: KEY PLAYERS, 2023- Company footprint- Disease footprint- End-user footprint- Region footprint
-
10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023PROGRESSIVE COMPANIESRESPONSIVE COMPANIESDYNAMIC COMPANIESSTARTING BLOCKSCOMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
-
10.7 COMPETITIVE SCENARIOPRODUCT LAUNCHES & APPROVALSDEALSEXPANSIONS
- 10.8 BRAND/PRODUCT COMPARISON
-
10.9 COMPANY VALUATION & FINANCIAL METRICSFINANCIAL METRICSCOMPANY VALUATION
-
11.1 KEY PLAYERSOLYMPUS CORPORATION- Business overview- Products offered- Recent developments- MnM viewBOSTON SCIENTIFIC CORPORATION- Business overview- Products offered- Recent developments- MnM viewMEDTRONIC PLC- Business overview- Products offered- Recent developments- MnM viewSTRYKER CORPORATION- Business overview- Products offered- Recent developments- MnM viewCOOK MEDICAL- Business overview- Products offered- Recent developments- MnM viewFUJIFILM CORPORATION- Business overview- Products offered- Recent developmentsCONMED CORPORATION- Business overview- Products offeredETHICON (A JOHNSON & JOHNSON SUBSIDIARY)- Business overview- Products offered- Recent developmentsMERIT MEDICAL SYSTEMS- Business overview- Products offered- Recent developmentsSTERIS PLC- Business overview- Products offeredKARL STORZ SE & CO. KG- Business overview- Products offered- Recent developments
-
11.2 OTHER PLAYERSSHAILI ENDOSCOPYTAEWOONG MEDICAL CO., LTD.HOBBS MEDICAL, INC.PENTAX MEDICALERBE ELEKTROMEDIZINAMBU A/SCAPSOVISION, INC.INTROMEDIC, INC.VIMEX ENDOSCOPYTRIVITRON HEALTHCAREMEDI-GLOBE CORPORATIONSONOSCAPE MEDICAL CORP.SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO. LTD.MEDSPIRA
- 12.1 DISCUSSION GUIDE
- 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
- 12.3 CUSTOMIZATION OPTIONS
- 12.4 RELATED REPORTS
- 12.5 AUTHOR DETAILS
- TABLE 1 STANDARD CURRENCY CONVERSION RATES
- TABLE 2 GLOBAL HEALTHCARE EXPENDITURES, BY REGION, 2022–2023
- TABLE 3 ASIA PACIFIC: HEALTHCARE EXPENDITURE, BY COUNTRY, 2022–2023
- TABLE 4 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: PORTER’S FIVE FORCES ANALYSIS
- TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 8 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 9 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 10 HS CODES FOR GASTROENTEROLOGY/GASTROINTESTINAL INSTRUMENTS
- TABLE 11 IMPORT DATA FOR ENDOSCOPIC DEVICES (NEEDLES, GUIDEWIRES, AND CATHETERS) (HS CODE 90189044), BY COUNTRY, 2019–2023 (USD THOUSAND)
- TABLE 12 EXPORT DATA FOR ENDOSCOPIC DEVICES (NEEDLES, GUIDEWIRES, AND CATHETERS) (HS CODE 90189044), BY COUNTRY, 2019–2023 (USD THOUSAND)
- TABLE 13 AVERAGE SELLING PRICE OF GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS, BY KEY PLAYER, 2023 (USD)
- TABLE 14 AVERAGE SELLING PRICE OF GASTROINTESTINAL PRODUCTS, BY REGION, 2021–2023
- TABLE 15 REIMBURSEMENT CODES FOR GASTROENTEROLOGY/GASTROINTESTINAL PROCEDURES
- TABLE 16 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: KEY CONFERENCES & EVENTS, 2024–2025
- TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
- TABLE 18 KEY BUYING CRITERIA FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
- TABLE 19 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: UNMET NEEDS
- TABLE 20 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: END-USER EXPECTATIONS
- TABLE 21 CASE STUDY 1: AI-ENHANCED CAPSULE ENDOSCOPY FOR SMALL BOWEL DISEASE DETECTION
- TABLE 22 CASE STUDY 2: RADIOFREQUENCY ABLATION FOR BARRETT'S ESOPHAGUS
- TABLE 23 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: AI INTEGRATION
- TABLE 24 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 25 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 26 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (THOUSAND UNITS)
- TABLE 27 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 28 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR FLEXIBLE ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 29 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR RIGID ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 30 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CAPSULE ENDOSCOPES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 31 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER ENDOSCOPY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 32 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 33 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, VOLUME DATA 2022–2029 (THOUSAND UNITS)
- TABLE 34 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 35 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 36 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MICROWAVE ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 37 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CRYOABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 38 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR LASER ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 39 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER ABLATION DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 40 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 41 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 42 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL MANOMETRY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 43 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR 4-HOUR PH IMPEDANCE TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 44 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ANORECTAL MANOMETRY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 45 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER MOTILITY TESTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 46 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 47 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 48 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR NEEDLE BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 49 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER BIOPSY DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 50 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 51 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (THOUSAND UNITS)
- TABLE 52 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 53 BILIARY STENTS OFFERED BY PROMINENT PLAYERS
- TABLE 54 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BILIARY STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 55 COLONIC STENTS OFFERED BY PROMINENT PLAYERS
- TABLE 56 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR COLONIC STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 57 DUODENAL STENTS OFFERED BY PROMINENT PLAYERS
- TABLE 58 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR DUODENAL STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 59 PANCREATIC STENTS OFFERED BY PROMINENT PLAYERS
- TABLE 60 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PANCREATIC STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 61 ESOPHAGEAL STENTS OFFERED BY PROMINENT PLAYERS
- TABLE 62 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL STENTS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 63 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 64 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 65 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ESOPHAGEAL PH MONITORING CATHETERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 66 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR WIRELESS PH MONITORING CAPSULES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 67 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR AMBULATORY PH MONITORING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 68 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 69 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 70 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTRIC BALLOONS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 71 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROINTESTINAL TUBES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 72 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR HEMORRHOID TREATMENT DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 73 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 74 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROINTESTINAL CANCERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 75 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD), BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 76 TYPES OF IBS WITH SEVERITY INDEX
- TABLE 77 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR IRRITABLE BOWEL SYNDROME (IBS), BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 78 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR INFLAMMATORY BOWEL DISEASE (IBD), BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 79 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 80 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 81 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 82 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR AMBULATORY SURGICAL CENTERS & INDEPENDENT DIAGNOSTIC CENTERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 83 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR CLINICS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 84 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 85 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 86 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 87 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 88 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 89 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 90 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 91 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 92 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 93 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 94 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 95 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 96 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 97 MEDICARE NATIONAL AVERAGE COVERAGE FOR OUTPATIENT PROCEDURES, 2024
- TABLE 98 LIST OF DEVICES THAT RECEIVED FDA APPROVALS BETWEEN 2020 AND 2023
- TABLE 99 US: MACROECONOMIC INDICATORS
- TABLE 100 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 101 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 102 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 103 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 104 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 105 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 106 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 107 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 108 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 109 US: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 110 CANADA: MACROECONOMIC INDICATORS
- TABLE 111 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 112 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 113 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 114 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 115 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 116 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 117 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 118 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 119 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 120 CANADA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 121 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 122 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 123 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 124 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 125 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 126 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 127 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 128 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 129 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 130 EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 131 GERMANY: MACROECONOMIC INDICATORS
- TABLE 132 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 133 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 134 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 135 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 136 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 137 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 138 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 139 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 140 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 141 GERMANY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 142 UK: MACROECONOMIC INDICATORS
- TABLE 143 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 144 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 145 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 146 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 147 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 148 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 149 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 150 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 151 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 152 UK: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 153 FRANCE: MACROECONOMIC INDICATORS
- TABLE 154 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 155 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 156 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 157 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 158 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 159 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 160 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 161 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 162 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 163 FRANCE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 164 ITALY: MACROECONOMIC INDICATORS
- TABLE 165 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 166 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 167 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 168 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 169 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 170 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 171 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 172 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 173 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 174 ITALY: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 175 SPAIN: MACROECONOMIC INDICATORS
- TABLE 176 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 177 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 178 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 179 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 180 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 181 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 182 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 183 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 184 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 185 SPAIN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 186 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 187 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 188 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 189 REST OF EUROPE: : GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 190 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 191 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 192 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 193 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 194 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 195 REST OF EUROPE: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 196 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
- TABLE 197 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 198 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 199 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 200 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 201 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 202 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 203 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 204 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 205 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 206 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 207 JAPAN: MACROECONOMIC INDICATORS
- TABLE 208 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 209 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 210 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 211 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 212 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 213 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 214 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 215 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 216 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 217 JAPAN: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 218 CHINA: MACROECONOMIC INDICATORS
- TABLE 219 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 220 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 221 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 222 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 223 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 224 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 225 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 226 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 227 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 228 CHINA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 229 INDIA: MACROECONOMIC INDICATORS
- TABLE 230 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 231 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 232 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 233 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 234 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 235 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 236 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 237 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 238 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 239 INDIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 240 AUSTRALIA: MACROECONOMIC INDICATORS
- TABLE 241 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 242 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 243 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 244 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 245 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 246 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 247 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 248 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 249 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 250 AUSTRALIA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 251 SOUTH KOREA: MACROECONOMIC INDICATORS
- TABLE 252 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 253 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 254 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 255 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 256 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 257 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 258 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 259 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 260 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 261 SOUTH KOREA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 262 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 263 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 264 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 265 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 266 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 267 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 268 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 269 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 270 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 271 REST OF ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 272 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 273 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 274 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 275 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 276 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 277 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 278 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 279 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 280 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 281 LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 282 BRAZIL: MACROECONOMIC INDICATORS
- TABLE 283 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 284 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 285 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 286 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 287 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 288 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 289 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 290 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 291 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 292 BRAZIL: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 293 MEXICO: MACROECONOMIC INDICATORS
- TABLE 294 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 295 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 296 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 297 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 298 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 299 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 300 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 301 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 302 MEXICO: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 303 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 304 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 305 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 306 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 307 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 308 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 309 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 310 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 311 REST OF LATIN AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 312 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
- TABLE 313 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 314 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 315 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 316 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 317 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 318 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 319 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 320 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 321 MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 322 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 323 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 324 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 325 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 326 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 327 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 328 GCC COUNTRIES GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 329 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 330 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 331 GCC COUNTRIES: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 332 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2022–2029 (USD MILLION)
- TABLE 333 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 334 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ABLATION DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 335 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR MOTILITY TESTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 336 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR BIOPSY DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 337 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR STENTING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 338 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR PH MONITORING DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 339 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR OTHER GASTROENTEROLOGY/GASTROINTESTINAL DEVICES, BY TYPE, 2022–2029 (USD MILLION)
- TABLE 340 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2022–2029 (USD MILLION)
- TABLE 341 REST OF MIDDLE EAST & AFRICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2022–2029 (USD MILLION)
- TABLE 342 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: DEGREE OF COMPETITION
- TABLE 343 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: DEVICE FOOTPRINT
- TABLE 344 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: DISEASE FOOTPRINT
- TABLE 345 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: END-USER FOOTPRINT
- TABLE 346 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: REGION FOOTPRINT
- TABLE 347 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: KEY START-UPS/SMES
- TABLE 348 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: PRODUCT LAUNCHES & APPROVALS, MAY 2020–MARCH 2024
- TABLE 349 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: DEALS, JANUARY 2020–FEBRUARY 2024
- TABLE 350 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: EXPANSIONS, JANUARY 2020–FEBRUARY 2024
- TABLE 351 OLYMPUS CORPORATION: COMPANY OVERVIEW
- TABLE 352 OLYMPUS CORPORATION: PRODUCTS OFFERED
- TABLE 353 OLYMPUS CORPORATION: PRODUCTS LAUNCHES & APPROVALS, JANUARY 2020–AUGUST 2024
- TABLE 354 OLYMPUS CORPORATION: DEALS, JANUARY 2020–AUGUST 2024
- TABLE 355 OLYMPUS CORPORATION: EXPANSIONS, JANUARY 2020–AUGUST 2024
- TABLE 356 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
- TABLE 357 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
- TABLE 358 BOSTON SCIENTIFIC CORPORATION: PRODUCTS LAUNCHES & APPROVALS, JANUARY 2020– AUGUST 2024
- TABLE 359 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2020–AUGUST 2024
- TABLE 360 MEDTRONIC PLC: COMPANY OVERVIEW
- TABLE 361 MEDTRONIC PLC: PRODUCTS OFFERED
- TABLE 362 MEDTRONIC PLC: PRODUCTS APPROVALS, JANUARY 2020–AUGUST 2024
- TABLE 363 MEDTRONIC PLC: DEALS, JANUARY 2020–AUGUST 2024
- TABLE 364 STRYKER CORPORATION: COMPANY OVERVIEW
- TABLE 365 STRYKER CORPORATION: PRODUCTS OFFERED
- TABLE 366 STRYKER CORPORATION: PRODUCT APPROVALS, JANUARY 2020–AUGUST 2024
- TABLE 367 STRYKER CORPORATION: DEALS, JANUARY 2020–AUGUST 2024
- TABLE 368 STRYKER CORPORATION: EXPANSIONS, JANUARY 2020–AUGUST 2024
- TABLE 369 COOK MEDICAL: COMPANY OVERVIEW
- TABLE 370 COOK MEDICAL: PRODUCTS OFFERED
- TABLE 371 COOK MEDICAL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020–AUGUST 2024
- TABLE 372 COOK MEDICAL: DEALS, JANUARY 2020–AUGUST 2024
- TABLE 373 FUJIFILM CORPORATION: COMPANY OVERVIEW
- TABLE 374 FUJIFILM CORPORATION: PRODUCTS OFFERED
- TABLE 375 FUJIFILM CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020–AUGUST 2024
- TABLE 376 FUJIFILM CORPORATION: OTHER DEVELOPMENTS, JANUARY 2020–AUGUST 2024
- TABLE 377 CONMED CORPORATION: COMPANY OVERVIEW
- TABLE 378 CONMED CORPORATION: PRODUCTS OFFERED
- TABLE 379 ETHICON: COMPANY OVERVIEW
- TABLE 380 ETHICON: PRODUCTS OFFERED
- TABLE 381 ETHICON: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020–AUGUST 2024
- TABLE 382 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW
- TABLE 383 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED
- TABLE 384 MERIT MEDICAL SYSTEMS: PRODUCT LAUNCHES, JANUARY 2020–AUGUST 2024
- TABLE 385 STERIS PLC: COMPANY OVERVIEW
- TABLE 386 STERIS PLC: PRODUCTS OFFERED
- TABLE 387 KARL STORZ SE & CO. KG: COMPANY OVERVIEW
- TABLE 388 KARL STORZ SE & CO. KG: PRODUCTS OFFERED
- TABLE 389 KARL STORZ SE & CO. KG: DEALS, JANUARY 2020–AUGUST 2024
- FIGURE 1 RESEARCH DESIGN
- FIGURE 2 PRIMARY SOURCES
- FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
- FIGURE 4 MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
- FIGURE 5 TOP-DOWN APPROACH
- FIGURE 6 MARKET SIZE ESTIMATION: DEMAND-SIDE ASSESSMENT
- FIGURE 7 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024–2029): IMPACT LEVEL OF CAGR
- FIGURE 8 CAGR PROJECTIONS
- FIGURE 9 DATA TRIANGULATION METHODOLOGY
- FIGURE 10 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DEVICE, 2024 VS. 2029 (USD MILLION)
- FIGURE 11 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY DISEASE, 2024 VS. 2029 (USD MILLION)
- FIGURE 12 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
- FIGURE 13 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET FOR ENDOSCOPY DEVICES, BY TYPE, 2024 VS. 2029 (USD MILLION)
- FIGURE 14 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: GEOGRAPHIC SNAPSHOT
- FIGURE 15 INCREASING PREVALENCE OF GI DISORDERS TO DRIVE MARKET GROWTH
- FIGURE 16 ENDOSCOPY DEVICES ACCOUNTED FOR LARGEST SHARE OF GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET IN 2023
- FIGURE 17 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
- FIGURE 18 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 19 ADVANCEMENTS IN TECHNOLOGY, FOCUS ON PREVENTIVE CARE, AND SHIFT TOWARD PATIENT-CENTERED APPROACHES
- FIGURE 20 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: VALUE CHAIN ANALYSIS
- FIGURE 21 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: PORTER’S FIVE FORCE ANALYSIS
- FIGURE 22 GLOBAL NUMBER OF PATENT PUBLICATIONS (JANUARY 2014–MARCH 2024)
- FIGURE 23 TOP APPLICANT & OWNER (COMPANIES/INSTITUTIONS) PATENTS (JANUARY 2014–MARCH 2024)
- FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
- FIGURE 25 KEY BUYING CRITERIA FOR GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS
- FIGURE 26 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: ECOSYSTEM ANALYSIS
- FIGURE 27 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: SUPPLY CHAIN ANALYSIS
- FIGURE 28 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: INVESTMENT & FUNDING SCENARIO, 2018–2023
- FIGURE 29 NORTH AMERICA: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET SNAPSHOT
- FIGURE 30 ASIA PACIFIC: GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET SNAPSHOT
- FIGURE 31 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET
- FIGURE 32 REVENUE ANALYSIS FOR KEY PLAYERS IN GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET (2019–2023)
- FIGURE 33 MARKET SHARE ANALYSIS OF KEY PLAYERS IN GASTROENTEROLOGY/ GASTROINTESTINAL PRODUCTS MARKET (2023)
- FIGURE 34 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
- FIGURE 35 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: COMPANY FOOTPRINT
- FIGURE 36 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
- FIGURE 37 GASTROENTEROLOGY/GASTROINTESTINAL PRODUCTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
- FIGURE 38 EV/EBITDA OF KEY VENDORS
- FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
- FIGURE 40 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2023)
- FIGURE 41 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)
- FIGURE 42 MEDTRONIC PLC: COMPANY SNAPSHOT (2023)
- FIGURE 43 STRYKER CORPORATION: COMPANY SNAPSHOT (2023)
- FIGURE 44 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2023)
- FIGURE 45 CONMED CORPORATION: COMPANY SNAPSHOT (2023)
- FIGURE 46 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2023)
- FIGURE 47 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2023)
- FIGURE 48 STERIS PLC: COMPANY SNAPSHOT (2023)
The study involved four major activities to estimate the current size of the gastroenterology products market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Gastrointestinal Products Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after obtaining information regarding the Gastroenterology Products Market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the gastrointestinal products market.; and key opinion leaders.
Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market. the following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the gastrointestinal products market includes the following details. The market sizing of the market was undertaken from the global side.
Country-Level Analysis
The size of the gastrointestinal products market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall gastrointestinal products market was obtained from secondary data and validated by primary participants to arrive at the total gastroenterology products market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region & Country)
-
Approach 1:
- Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends.
-
Approach 2:
- Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews).
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Gastroenterology/Gastrointestinal Products Market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Global Gastrointestinal Products Market Size: Bottom-Up Approach
Global Gastrointestinal Products Market Size: Top-Down Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the gastrointestinal products market.
Market Definition
Gastroenterology products encompass a variety of medical devices, diagnostic tools, and pharmaceuticals designed to diagnose, treat, and manage diseases and disorders of the gastrointestinal tract. These products include endoscopes, capsule endoscopy systems, ablation devices, stents, and specialized medications aimed at conditions like GERD, IBD, and colorectal cancer. Their purpose is to improve patient outcomes by offering advanced solutions for both diagnostic and therapeutic procedures within the GI tract.
Key Stakeholders
- Medical Device Manufacturers
- Healthcare Institutions (hospitals and outpatient clinics)
- Distributors and Suppliers
- Research Institutes
- Health Insurance Payers
- Market Research and Consulting Firms
Report Objectives
- To define, describe, segment, and forecast the global gastrointestinal Products Market by devices, diseases end users, and region.
- To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall gastrointestinal products market.
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
- To forecast the size of the gastroenterology products market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile key players in the global gastrointestinal products market and comprehensively analyze their core competencies2 and market shares.
- To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
- To benchmark players within the gastrointestinal products market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Latin American apheresis into specific countries and, the Middle East, and Africa apheresis into specific countries and further breakdown of the European apheresis into specific countries
Growth opportunities and latent adjacency in Gastrointestinal Products Market